Cue Biopharma Financial Flexibility Index
Cue Biopharma financial flexibility index. Cue Biopharma (CUE) has a Financial Flexibility Index of -0.49x as of September 2025. Free cash flow of $-9.02 Million (operating CF $-9.02 Million minus capex $0.00) represents 0% of total liabilities ($18.40 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cue Biopharma (2015–2024)
Financial flexibility index of Cue Biopharma from 2015 to 2024. Historical Financial Flexibility Index trend for Cue Biopharma across 10 annual periods. Explore Cue Biopharma debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cue Biopharma Financial Flexibility Index by Year (2015–2024)
Cue Biopharma financial flexibility index by year from 2015 to 2024. Year-by-year free cash flow to debt coverage for Cue Biopharma. For the full cash flow conversion analysis, see Cue Biopharma cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.47x | $-36.26 Million | $-36.33 Million | $14.69 Million | ▼ -51.0% |
| 2023 | -1.63x | $-39.96 Million | $-39.96 Million | $24.45 Million | ▼ -0.5% |
| 2022 | -1.63x | $-41.63 Million | $-41.81 Million | $25.60 Million | ▲ +23.2% |
| 2021 | -2.12x | $-37.92 Million | $-38.84 Million | $17.91 Million | ▼ -36.9% |
| 2020 | -1.55x | $-31.90 Million | $-32.49 Million | $20.62 Million | ▲ +14.4% |
| 2019 | -1.81x | $-30.75 Million | $-30.80 Million | $17.02 Million | ▲ +16.2% |
| 2018 | -2.16x | $-24.56 Million | $-26.41 Million | $11.39 Million | ▼ -4.9% |
| 2017 | -2.05x | $-10.99 Million | $-12.19 Million | $5.35 Million | ▲ +58.4% |
| 2016 | -4.94x | $-5.45 Million | $-5.97 Million | $1.10 Million | ▼ -105.7% |
| 2015 | -2.40x | $-903.28K | $-1.66 Million | $376.30K | — |